157 related articles for article (PubMed ID: 30079814)
1. Social support deficit and depression treatment outcomes in patients with acute coronary syndrome: Findings from the EsDEPACS study.
Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Yoon JS; Hong YJ; Ahn Y; Jeong MH; Kim JM
Int J Psychiatry Med; 2019 Jan; 54(1):39-52. PubMed ID: 30079814
[TBL] [Abstract][Full Text] [Related]
2. Effects of depression screening on psychiatric outcomes in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
Int J Cardiol; 2015; 190():114-21. PubMed ID: 25918060
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
[TBL] [Abstract][Full Text] [Related]
4. Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
Kim JM; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Kang H; Yoon JS
Int J Cardiol; 2016 Sep; 219():225-30. PubMed ID: 27336191
[TBL] [Abstract][Full Text] [Related]
5. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
[TBL] [Abstract][Full Text] [Related]
6. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
8. Predictors of depressive disorder following acute coronary syndrome: Results from K-DEPACS and EsDEPACS.
Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2015 Aug; 181():1-8. PubMed ID: 25913538
[TBL] [Abstract][Full Text] [Related]
9. Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
Kim JM; Stewart R; Lee YS; Lee HJ; Kim MC; Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Kim JH; Ahn Y; Jeong MH; Yoon JS
JAMA; 2018 Jul; 320(4):350-358. PubMed ID: 30043065
[TBL] [Abstract][Full Text] [Related]
10. BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies.
Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Psychoneuroendocrinology; 2015 Dec; 62():159-65. PubMed ID: 26313133
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
12. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).
Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Birket-Smith M
Trials; 2009 Apr; 10():20. PubMed ID: 19351383
[TBL] [Abstract][Full Text] [Related]
14. Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.
Kim JM; Stewart R; Bae KY; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Sleep; 2015 Jul; 38(7):1105-11. PubMed ID: 25581916
[TBL] [Abstract][Full Text] [Related]
15. Influences of the Big Five personality traits on the treatment response and longitudinal course of depression in patients with acute coronary syndrome: A randomised controlled trial.
Kim SY; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2016 Oct; 203():38-45. PubMed ID: 27280961
[TBL] [Abstract][Full Text] [Related]
16. Modifying effects of depression on the association between BDNF methylation and prognosis of acute coronary syndrome.
Kim JM; Stewart R; Kim JW; Kang HJ; Lee JY; Kim SY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Brain Behav Immun; 2019 Oct; 81():422-429. PubMed ID: 31255678
[TBL] [Abstract][Full Text] [Related]
17. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial.
Almeida OP; Ford AH; Hirani V; Singh V; vanBockxmeer FM; McCaul K; Flicker L
Br J Psychiatry; 2014 Dec; 205(6):450-7. PubMed ID: 25257064
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
19. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome.
Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2016 Apr; 194():1-8. PubMed ID: 26795846
[TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
